CES & MET Webinar for Healthcare Practitioners
Webinar Signup Form
Alpha-Stim® has been on the market as a pain and mental health solution for over 37 years and has more research than any other therapeutic MET or CES device. There are over 100 studies published to date and over 20 currently underway. Our research is so good even our competitors use it! FDA accepts a broad range of waveform parameters for the CES category, which is not unusual. For example, both aspirin and morphine are categorized as analgesics but we all understand the considerable differences between the two. Only Alpha-Stim is proven to get the results shown in Alpha-Stim research.
Instructions for Use
Alpha-Stim’s patented waveform is delivered using our unique, patented Earclip Electrodes, Smart Probes or AS-Trodes™. The ears are an efficient and easy way to apply electrodes to direct the current across the brain stem. LORETA (computerized EEG) studies prove that Alpha-Stim® CES device technology affects the whole brain from the earclip application.
Handheld probes or attachable self-adhesive electrodes are used for site-specific microcurrent electrical therapy. The webinar will include detailed protocols developed specifically for Alpha-Stim and proven to provide acute, post-traumatic and chronic pain relief and pain management.
Contraindications & Adverse Effects
We’ll cover risk information and adverse effects from data on approximately 8,800 patients participating in 144 controlled studies and open clinical trials.
Chief Science & Clinical Officer
Dr. Jeffrey Marksberry serves as the Chief Science & Clinical Officer for Electromedical Products International Inc. (EPI). Dr. Marksberry has more than ten years of experience in medical education as a special consultant for two international medical schools. He also has expertise in medical licensure regulations for all 50 states and sovereign Native American governments as well as Canada, Australia, New Zealand and The Netherlands. His focus areas included writing curriculum for continuing medical education programs for medical schools and universities. In 2014, Dr. Marksberry was granted the designation of Certified Clinical Research Professional by the Society of Clinical Research Associates.
In 2015, Dr. Marksberry co-authored a chapter in the book Bioelectromagnetic and Subtle Energy Medicine 2nd Edition. (Kirsch DL and Marksberry JM. The Evolution of Cranial Electrotherapy Stimulation for Anxiety, Insomnia, Depression and Pain and Its Potential for Other Indications, p 189-209. Bioelectromagnetic and Subtle Energy Medicine 2nd Edition, Rosch, Paul J. (Ed) CRC Press Boca Raton.) Most recently he contributed to the book, Complementary and Integrative Treatments in Psychiatric Practice (American Psychiatric Association, 2017), and was featured in Justin Smith’s 2017 documentary movie, Body Electric: Electroceuticals and the Future of Medicine, and co-authored a chapter on CES in the book Using Technology in Mental Health Practice published by the American Psychological Association (2018).
Director of Science and Education
Dr. Steve Haltiwanger is currently the Director of Science and Education at EPI. In the past, he has been the Medical Director of two other companies. After earning a B.S. in Professional Chemistry from Valdosta State University in Valdosta, Georgia, Dr. Haltiwanger attended the Medical College of Georgia. While there he completed medical school and a one-year fellowship in Pathology. He graduated from the Medical College of Georgia with an M.D. degree in 1980. He completed a Psychiatry and Neurology residency at the University of South Carolina in 1984. In 2003, he became a CCN (Certified Clinical Nutritionist). He currently is a member of the scientific council of the International and American Association of Clinical Nutritionists.
Over the last 20 years, Dr. Haltiwanger has been involved in 72 research studies. Dr. Haltiwanger’s past research includes electromagnetic, acoustic and phototherapy treatments. He has also researched the effects of PEMF on neurological diseases (multiple sclerosis and diabetic neuropathy).
In the last 34 years has lectured in 17 countries and at dozens of scientific conferences.